IL149379A0 - Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same - Google Patents

Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same

Info

Publication number
IL149379A0
IL149379A0 IL14937901A IL14937901A IL149379A0 IL 149379 A0 IL149379 A0 IL 149379A0 IL 14937901 A IL14937901 A IL 14937901A IL 14937901 A IL14937901 A IL 14937901A IL 149379 A0 IL149379 A0 IL 149379A0
Authority
IL
Israel
Prior art keywords
peptides
concatemer
apolipoprotein
epitope
same
Prior art date
Application number
IL14937901A
Other languages
English (en)
Original Assignee
Hyo Joon Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyo Joon Kim filed Critical Hyo Joon Kim
Priority claimed from KR10-2001-0054005A external-priority patent/KR100472841B1/ko
Publication of IL149379A0 publication Critical patent/IL149379A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL14937901A 2000-09-04 2001-09-04 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same IL149379A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20000052055 2000-09-04
KR10-2001-0054005A KR100472841B1 (ko) 2000-09-04 2001-09-04 아포지단백질 비-100의 에피토프에 대한 모조 펩타이드,그들의 연쇄물 또는 변형체와 이들을 함유하는 백신 조성물
PCT/KR2001/001492 WO2002020040A1 (en) 2000-09-04 2001-09-04 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same

Publications (1)

Publication Number Publication Date
IL149379A0 true IL149379A0 (en) 2002-11-10

Family

ID=26638363

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14937901A IL149379A0 (en) 2000-09-04 2001-09-04 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same

Country Status (18)

Country Link
US (1) US6825318B2 (cs)
EP (1) EP1315517B1 (cs)
JP (1) JP2004508029A (cs)
CN (1) CN1231262C (cs)
AU (1) AU8628601A (cs)
BG (1) BG106655A (cs)
BR (1) BR0107175A (cs)
CA (1) CA2389739A1 (cs)
CZ (1) CZ20021571A3 (cs)
EE (1) EE200200238A (cs)
HU (1) HUP0203251A2 (cs)
IL (1) IL149379A0 (cs)
LT (1) LT4989B (cs)
MX (1) MXPA02004505A (cs)
NO (1) NO20022147D0 (cs)
RU (1) RU2313536C2 (cs)
SK (1) SK6312002A3 (cs)
WO (1) WO2002020040A1 (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176013B2 (en) * 2003-06-11 2007-02-13 Schering Aktiengesellschaft Modified corin molecules having substitute activation sequences and uses thereof
KR100639397B1 (ko) * 2004-03-18 2006-10-26 (주)에스제이바이오메드 항비만용 면역원성 하이브리드 폴리펩타이드 및 이를포함하는 항비만 백신 조성물
US20070054298A1 (en) * 2005-08-12 2007-03-08 Kent Kirshenbaum Methods for enzyme-mediated coupling of oligomers
WO2007075335A2 (en) * 2005-12-16 2007-07-05 The Regents Of The University Of California Modulation of in utero immune programming
US8961982B2 (en) * 2005-12-16 2015-02-24 The Regents Of The University Of California Modulation of developmental immune programming and protection against cardiovascular disease, diabetes, infectious diseases, and cancer
US20110002955A1 (en) * 2006-09-25 2011-01-06 Sj Biomed Inc. Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
CN103520713B (zh) * 2013-10-16 2015-10-28 西北农林科技大学 一种ApoB100酵母重组疫苗及其制备方法和应用
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
WO2017210360A1 (en) 2016-05-31 2017-12-07 Cardiovax, Llc Methods for diagnosing and treating systemic lupus erythematosus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3215310A1 (de) * 1982-04-23 1983-10-27 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
US6309853B1 (en) * 1994-08-17 2001-10-30 The Rockfeller University Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
DE69838544T2 (de) * 1997-03-04 2008-07-24 Savient Pharmaceuticals, Inc. Isolierung von gewebespezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
AU2801299A (en) * 1998-03-04 1999-09-20 Bio-Technology General Corporation Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
WO2001064008A2 (en) * 2000-03-03 2001-09-07 Smithkline Beecham Biologicals S.A. Vaccine for the treatment of artherosclerosis

Also Published As

Publication number Publication date
JP2004508029A (ja) 2004-03-18
NO20022147L (no) 2002-05-03
CA2389739A1 (en) 2002-03-14
CZ20021571A3 (cs) 2002-09-11
CN1231262C (zh) 2005-12-14
MXPA02004505A (es) 2004-09-10
HUP0203251A2 (hu) 2003-01-28
WO2002020040A1 (en) 2002-03-14
EP1315517A4 (en) 2005-02-09
LT4989B (lt) 2003-01-27
BG106655A (bg) 2004-08-31
CN1392798A (zh) 2003-01-22
BR0107175A (pt) 2002-07-02
LT2002051A (en) 2002-09-25
US20030211997A1 (en) 2003-11-13
RU2003109439A (ru) 2004-07-20
EP1315517B1 (en) 2010-10-20
AU8628601A (en) 2002-03-22
EE200200238A (et) 2003-06-16
SK6312002A3 (en) 2002-09-10
RU2313536C2 (ru) 2007-12-27
NO20022147D0 (no) 2002-05-03
EP1315517A1 (en) 2003-06-04
US6825318B2 (en) 2004-11-30

Similar Documents

Publication Publication Date Title
AU5943201A (en) Modified peptides as therapeutic agents
IL153970A0 (en) Promyostatin peptides and methods of using same
IL155842A0 (en) Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus
HU229997B1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
IL151355A0 (en) Vaccine for the treatment of artherosclerosis
HUP0002942A3 (en) Peptides having serine protease inhibiting effect pharmaceutical compositions comprising thereof and their use
AU2001286730A1 (en) An iap binding peptide or polypeptide and methods of using the same
EP1021202A4 (en) IMMUNOGENIC PEPTIDES FROM HPV E7 PROTEIN
AU2002365396A8 (en) Peptides, peptide compositions,and methods of use in binding p 185
EP1315517A4 (en) MIMETIC PEPTIDES FOR THE EPITOPE OF APOLIPOPROTEIN B-100, CONCATEMERS AND ITS MODIFIED PEPTIDES, AND VACCINE COMPOSITION COMPRISING THE SAME
EP1419175A4 (en) PEPTIDES OF REPLIKIN AND THEIR USE
AU2001275409A1 (en) Methods and compositions for controlled polypeptide synthesis
AUPQ712000A0 (en) Antigenic peptide fragments of VapA protein, and uses thereof
IL152202A0 (en) Human kcnq5 polypeptide and pharmaceutical compositions containing the same
IL154357A0 (en) Stress proteins and peptides and methods of use thereof
AU2002217863A1 (en) Homing peptide multimers, their preparation and uses
IL150458A0 (en) Novel haptotactic peptides
IL152609A0 (en) Liposomal compositions comprising haptotactic peptides and uses thereof
GB0030309D0 (en) Antibodies,Peptides,Analogs and uses thereof
GB0217327D0 (en) Peptide fragments of colostrinin and their use
AU2001267613A1 (en) Adjuvant composition comprising FHA protein or fragment of FHA protein in free form
WO2000042063A3 (de) Peptide zur inhibierung von hbv-core-proteinen
AU2002321852A1 (en) Recombinant polypeptide for immunocastration and vaccine comprising the same
GB0108752D0 (en) Peptide epitopes and uses thereof
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof